Diagnostic high mechanical index (MI) ultrasound in conjunction with microbubble infusion in patients with acute ST-elevation myocardial infarction (STEMI) may be a method of achieving early recanalization, (sonothrombolysis). To evaluate the safety, efficacy and prognostic impact of sonothrombolysis in patients with acute coronary syndromes (ACS). We will randomize 540 patients with anterior STEMI in the “High Ultrasound Mechanical Index and MicrobuBBLEs to reduce acute myocardial infarction burden” (HUBBLE-I). Sonothrombolysis (50 min) was performed using multiple intermittent high MI impulses when microbubbles were imaged within the risk area (Therapy Group) or only 3 projections of low MI imaging alone plus microbubbles (Control Group) in 5 patient subgroups: G1-STEMI pre-PCI; G2-STEMI after lytic therapy; G3-Unstable angina and non-STEMI; G4-STEMI post-PCI; G5-STEMI pre-PCI treated in ambulances. Recanalization, ejection fraction, troponin and MB-CK levels were acquired at baseline, pre-PCI and follow-up. Global longitudinal strain was serially measured. The number of patients randomized to control versus therapy was 47(23/24), as follows: G1- 12 (5/7); G2- 13 (9/4); G3- 14 (8/6); G4- 8 (4/4) and G5- 0(0/0). This multicenter, Phase III randomized trial in patients with ACS treated by sonothrombolysis will assess safety, efficacy, and prognostic impact of this therapy.
Read full abstract